StockData
Organogenesis Holdings Inc. logo

Organogenesis Holdings Inc. (ORGO) stock

ORGONasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/30
$0.80−0.01 (-0.86%)

Close on Nov 16, 2026Market cap $103.34MP/E –Yield –

Organogenesis EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Organogenesis's EV/EBITDA was 11.5× on Jul 31, 2026, against 276.5× a year earlier. Over the last 5 years it ranged from 3.4× to 327.8×, with a median of 14.9×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 202611.5×−80.5
2025Dec 31, 202592.0×−184.5
2024Oct 31, 2024276.5×+257.0
2023Dec 29, 202319.5×+12.1
2022Dec 30, 20227.3×−7.3
2021Dec 31, 202114.7×−218.2
2020Dec 31, 2020232.9×–

More Organogenesis figures

See a number that looks wrong?